Modi Mansi B, Donga Shilpa B, Dei Laxmipriya
Ayurvedic Practitioner, Vadodara, Gujarat, India.
Ayu. 2012 Oct;33(4):511-6. doi: 10.4103/0974-8520.110529.
Menopause is a gradual and natural transitional phase of adjustment between the active and inactive ovarian function and occupies several years of a women's life and involves biological and psychological changes adjustments. The present clinical trial was designed as per Ayurveda clinical trials protocol to evaluate the efficacy of Ashokarishta, Ashwagandha Churna and Praval Pishti in the management of menopausal syndrome. It was directed by Central Council for Research in Ayurvedic Sciences as randomized open clinical trial. Total 52 patients were registered in the study, out of which 51 patients completed the study. Specialized rating scales like Kupperman Index Score as well as Menopause Rating Scale (MRS) and Menopause Specific Quality of Life (MENQOL) questionnaires were adopted for diagnostic as well as assessment criteria. The effects were examined based on MRS and MENQOL. Results were analyzed statistically using Wilcoxon matched paired test and 't' test. Highly significant (P < 0.01) reduction was found in the symptoms of MRS as well as MENQOL. Finally, it can be stated that combined treatment of above drugs gives better result in both somatic as well as psychological complaints in women with mild to moderate symptoms of menopausal syndrome.
更年期是卵巢功能从活跃到不活跃的一个逐渐且自然的过渡调整阶段,会持续数年,涉及女性生活的多个方面,包括生理和心理的变化与调整。本临床试验按照阿育吠陀医学临床试验方案设计,以评估阿育吠陀补汁、印度人参粉和珊瑚粉在治疗更年期综合征方面的疗效。该试验由阿育吠陀科学中央研究理事会指导,为随机开放临床试验。共有52名患者登记参与该研究,其中51名患者完成了研究。采用了诸如库珀曼指数评分以及更年期评定量表(MRS)和更年期特定生活质量(MENQOL)问卷等专业评定量表作为诊断和评估标准。基于MRS和MENQOL对疗效进行检查。使用威尔科克森配对检验和“t”检验对结果进行统计学分析。发现MRS和MENQOL的症状均有极显著(P < 0.01)的减轻。最后,可以得出结论,上述药物联合治疗对轻度至中度更年期综合征症状的女性的躯体和心理不适均有较好疗效。